Research Library — Pipeline Outlook | Reta Compare
15 research articles in Pipeline Outlook. Page 1 of 1.
Articles
- Timeline for Quad-Agonist GLP Drugs: A Pipeline Outlook
- Phase 1 Quad-Agonists in Clinical Trials
- Preclinical Quad-Agonists Poised for Clinical Development
- Regulatory Path for Quad-Agonist Obesity Drugs at the FDA
- EMA and Quad-Agonist Approvals in Europe: A Pipeline Outlook
- China's Race to Approve Domestic Multi-Agonist GLP Drugs
- Manufacturing Challenges for Quad-Agonist Peptides in Metabolic Drug Development
- The Future of Quad-Agonist GLP Drugs in Compounding Pharmacy
- Patent Landscape of Quad-Agonist GLP Drugs
- Biosimilar Quad-Agonists: Exploring Their Plausibility
- Cost-Effectiveness Analyses Expected for Quad-Agonist GLP Drugs
- Insurance Coverage Outlook for Next-Generation GLP-1 Drugs
- Anticipated Drug-Drug Interactions with Quad-Agonist GLP Drugs
- Long-Term Safety Studies Required for Quad-Agonist GLP Drugs
- Pancreatitis, Thyroid C-Cell, and Gallbladder Risks in Quad-Agonists